Ambea Sees Post-Merger Margin Target Hit by 2028

Ambea states that following its merger with Humana, it expects to achieve its adjusted EBITDA margin target of 9.5% by end-2028. The claim is a forward-looking corporate projection, not yet corroborated by financial results. This matters as it signals management's confidence in merger synergies, potentially supporting equity sentiment.